Log In
BCIQ
Print this Print this
 

B cell lymphoma 2 (BCL-2) (BCL2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting B cell lymphoma 2 (BCL-2) (BCL2)

BCIQ
Print ChartPrint this
2 5 2 4 1 0 1 0 0 0
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase III
Autoimmune

0

1

0

0

0

Cancer

2

5

2

4

1




 Products Targeting B cell lymphoma 2 (BCL-2) (BCL2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$525.0M

$225.0M

$300.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today